{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:42:58Z","timestamp":1790430178516,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003669","name":"Research of Korea Centers for Disease Control and Prevention","doi-asserted-by":"crossref","award":["2018-ER6204-00"],"award-info":[{"award-number":["2018-ER6204-00"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018R1A6A1A03025810"],"award-info":[{"award-number":["2018R1A6A1A03025810"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI18C0713"],"award-info":[{"award-number":["HI18C0713"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Abnormal iron accumulation around the substantia nigra (SN) is a diagnostic indicator of Parkinsonism. This study aimed to identify iron-related microarchitectural changes around the SN of brains with progressive supranuclear palsy (PSP) via postmortem validations and in vivo magnetic resonance imaging (MRI). 7\u00a0T high-resolution MRI was applied to two postmortem brain tissues, from one normal brain and one PSP brain. Histopathological examinations were performed to demonstrate the molecular origin of the high-resolution postmortem MRI findings, by using ferric iron staining, myelin staining, and two-dimensional laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS) imaging. In vivo iron-related MRI was performed on five healthy controls, five patients with Parkinson\u2019s disease (PD), and five patients with PSP. In the postmortem examination, excessive iron deposition along the myelinated fiber at the anterior SN and third cranial nerve (oculomotor nerve) fascicles of the PSP brain was verified by LA-ICP-MS. This region corresponded to those with high\n                    <jats:italic>R<\/jats:italic>\n                    <jats:sub>\n                      <jats:italic>2<\/jats:italic>\n                    <\/jats:sub>\n                    <jats:sup>\n                      <jats:italic>*<\/jats:italic>\n                    <\/jats:sup>\n                    values and positive susceptibility from quantitative susceptibility mapping (QSM), but was less sensitive in Perls\u2019 Prussian blue staining. In in vivo susceptibility-weighted imaging, hypointense pixels were observed in the region between the SN and red nucleus (RN) in patients with PSP, but not in healthy controls and patients with PD.\n                    <jats:italic>R<\/jats:italic>\n                    <jats:sub>\n                      <jats:italic>2<\/jats:italic>\n                    <\/jats:sub>\n                    <jats:sup>\n                      <jats:italic>*<\/jats:italic>\n                    <\/jats:sup>\n                    and QSM values of such region were significantly higher in patients with PSP compared to those in healthy controls and patients with PD as well (vs. healthy\u00a0control:\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.008; vs. PD:\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.008). Thus, excessive iron accumulation along the myelinated fibers at the anterior SN and oculomotor nerve fascicles may be a pathological characteristic and crucial MR biomarker in a brain with PSP.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-82469-w","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T06:10:36Z","timestamp":1612332636000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Iron accumulation in the oculomotor nerve of the progressive supranuclear palsy brain"],"prefix":"10.1038","volume":"11","author":[{"given":"Hansol","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Jun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Joo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gi Yeong","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hyeok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HyungJoon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,3]]},"reference":[{"issue":"4","key":"82469_CR1","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","volume":"114","author":"DT Dexter","year":"1991","unstructured":"Dexter, D. T. et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson\u2019s disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114(4), 1953\u20131975 (1991).","journal-title":"Brain"},{"issue":"10","key":"82469_CR2","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","volume":"13","author":"RJ Ward","year":"2014","unstructured":"Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R. & Zecca, L. The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol. 13(10), 1045\u20131060 (2014).","journal-title":"Lancet Neurol."},{"issue":"6","key":"82469_CR3","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/j.1471-4159.2010.07132.x","volume":"118","author":"J Sian-H\u00fclsmann","year":"2011","unstructured":"Sian-H\u00fclsmann, J., Mandel, S., Youdim, M. B. & Riederer, P. The relevance of iron in the pathogenesis of Parkinson\u2019s disease. J. Neurochem. 118(6), 939\u2013957 (2011).","journal-title":"J. Neurochem."},{"key":"82469_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/jnc.13425","volume":"139","author":"AA Belaidi","year":"2016","unstructured":"Belaidi, A. A. & Bush, A. I. Iron neurochemistry in Alzheimer\u2019s disease and Parkinson\u2019s disease: Targets for therapeutics. J. Neurochem. 139, 179\u2013197 (2016).","journal-title":"J. Neurochem."},{"issue":"1\u20132","key":"82469_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.mrfmmm.2003.08.004","volume":"531","author":"M Kruszewski","year":"2003","unstructured":"Kruszewski, M. Labile iron pool: The main determinant of cellular response to oxidative stress. Mutat. Res. Fundam. Mol. Mech. Mutagen. 531(1\u20132), 81\u201392 (2003).","journal-title":"Mutat. Res. Fundam. Mol. Mech. Mutagen."},{"key":"82469_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.09.012","volume":"155","author":"FA Zucca","year":"2017","unstructured":"Zucca, F. A. et al. Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson\u2019s disease. Prog. Neurobiol. 155, 96\u2013119 (2017).","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"82469_CR7","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1471-4159.2009.06470.x","volume":"112","author":"DW Lee","year":"2010","unstructured":"Lee, D. W. & Andersen, J. K. Iron elevations in the aging Parkinsonian brain: A consequence of impaired iron homeostasis?. J. Neurochem. 112(2), 332\u2013339 (2010).","journal-title":"J. Neurochem."},{"issue":"5","key":"82469_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1134\/S0022093014050020","volume":"50","author":"EG Sukhorukova","year":"2014","unstructured":"Sukhorukova, E. G., Alekseeva, O. S. & Korzhevsky, D. E. Catecholaminergic neurons of mammalian brain and neuromelanin. J. Evol. Biochem. Physiol. 50(5), 383\u2013391 (2014).","journal-title":"J. Evol. Biochem. Physiol."},{"key":"82469_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fneur.2019.00074","volume":"10","author":"JH Lee","year":"2019","unstructured":"Lee, J. H. & Lee, M. S. Brain iron accumulation in atypical parkinsonian syndromes: In vivo MRI evidences for distinctive patterns. Front. Neurol. 10, 74 (2019).","journal-title":"Front. Neurol."},{"issue":"suppl 1","key":"82469_CR10","doi-asserted-by":"crossref","first-page":"i10","DOI":"10.1136\/jnnp.72.suppl_1.i10","volume":"72","author":"DJ Brooks","year":"2002","unstructured":"Brooks, D. J. Diagnosis and management of atypical Parkinsonian syndromes. J. Neurol. Neurosurg. Psychiatry 72(suppl 1), i10\u2013i16 (2002).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"8","key":"82469_CR11","doi-asserted-by":"publisher","first-page":"a009258","DOI":"10.1101\/cshperspect.a009258","volume":"2","author":"DW Dickson","year":"2012","unstructured":"Dickson, D. W. Parkinson\u2019s disease and parkinsonism: Neuropathology. Cold Spring Harb. Perspect. Med. 2(8), a009258 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"82469_CR12","first-page":"33","volume":"42","author":"F Grandas","year":"1994","unstructured":"Grandas, F. & Esteban, A. Eyelid motor abnormalities in progressive supranuclear palsy. J. Neural Transm. 42, 33\u201341 (1994).","journal-title":"J. Neural Transm."},{"issue":"2","key":"82469_CR13","doi-asserted-by":"publisher","first-page":"s81","DOI":"10.1007\/s100720200080","volume":"23","author":"P Lamberti","year":"2002","unstructured":"Lamberti, P., De Mari, M., Zenzola, A., Aniello, M. S. & Defazio, G. Frequency of apraxia of eyelid opening in the general population and in patients with extrapyramidal disorders. Neurol. Sci. 23(2), s81\u2013s82 (2002).","journal-title":"Neurol. Sci."},{"issue":"12","key":"82469_CR14","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s00234-010-0677-6","volume":"52","author":"D Gupta","year":"2010","unstructured":"Gupta, D., Saini, J., Kesavadas, C., Sarma, P. S. & Kishore, A. Utility of susceptibility-weighted MRI in differentiating Parkinson\u2019s disease and atypical parkinsonism. Neuroradiology 52(12), 1087\u20131094 (2010).","journal-title":"Neuroradiology"},{"key":"82469_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.parkreldis.2017.08.029","volume":"44","author":"H Sj\u00f6str\u00f6m","year":"2017","unstructured":"Sj\u00f6str\u00f6m, H., Granberg, T., Westman, E. & Svenningsson, P. Quantitative susceptibility mapping differentiates between Parkinsonian disorders. Parkinsonism Relat. Disord. 44, 51\u201357 (2017).","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"82469_CR16","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1148\/radiol.12102273","volume":"266","author":"P Foroutan","year":"2013","unstructured":"Foroutan, P. et al. Progressive supranuclear palsy: High-field-strength MR microscopy in the human substantia nigra and globus pallidus. Radiology 266(1), 280\u2013288 (2013).","journal-title":"Radiology"},{"key":"82469_CR17","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.nicl.2016.11.015","volume":"13","author":"LA Massey","year":"2017","unstructured":"Massey, L. A. et al. 9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease. NeuroImage Clin. 13, 154\u2013163 (2017).","journal-title":"NeuroImage Clin."},{"key":"82469_CR18","doi-asserted-by":"publisher","first-page":"116625","DOI":"10.1016\/j.neuroimage.2020.116625","volume":"211","author":"H Lee","year":"2020","unstructured":"Lee, H. et al. MRI T2 and T2* relaxometry to visualize neuromelanin in the dorsal substantia nigra pars compacta. NeuroImage. 211, 116625 (2020).","journal-title":"NeuroImage."},{"key":"82469_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fnmol.2018.00276","volume":"11","author":"SS Rao","year":"2018","unstructured":"Rao, S. S. & Adlard, P. A. Untangling tau and iron: Exploring the interaction between iron and tau in neurodegeneration. Front. Mol. Neurosci. 11, 276 (2018).","journal-title":"Front. Mol. Neurosci."},{"key":"82469_CR20","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3389\/fneur.2019.01125","volume":"10","author":"A Shoeibi","year":"2019","unstructured":"Shoeibi, A., Olfati, N. & Litvan, I. Frontrunner in translation: Progressive supranuclear palsy. Front. Neurol. 10, 1125 (2019).","journal-title":"Front. Neurol."},{"issue":"2","key":"82469_CR21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jalz.2007.01.019","volume":"3","author":"G Bartzokis","year":"2007","unstructured":"Bartzokis, G., Lu, P. H. & Mintz, J. Human brain myelination and amyloid beta deposition in Alzheimer\u2019s disease. Alzheimer\u2019s Dementia. 3(2), 122\u2013125 (2007).","journal-title":"Alzheimer's Dementia."},{"issue":"6","key":"82469_CR22","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.tins.2019.03.009","volume":"42","author":"HE M\u00f6ller","year":"2019","unstructured":"M\u00f6ller, H. E. et al. Iron, myelin, and the brain: Neuroimaging meets neurobiology. Trends Neurosci. 42(6), 384\u2013401 (2019).","journal-title":"Trends Neurosci."},{"issue":"11","key":"82469_CR23","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/mp.2015.192","volume":"21","author":"M Heidari","year":"2016","unstructured":"Heidari, M. et al. Brain iron accumulation affects myelin-related molecular systems implicated in a rare neurogenetic disease family with neuropsychiatric features. Mol. Psychiatry. 21(11), 1599\u20131607 (2016).","journal-title":"Mol. Psychiatry."},{"key":"82469_CR24","first-page":"930501","volume":"2016","author":"ME Peckham","year":"2016","unstructured":"Peckham, M. E. et al. Novel pattern of iron deposition in the fascicula nigrale in patients with Parkinson\u2019s disease: A pilot study. Radiol. Res. Pract. 2016, 930501 (2016).","journal-title":"Radiol. Res. Pract."},{"issue":"4","key":"82469_CR25","doi-asserted-by":"publisher","first-page":"e3546","DOI":"10.1002\/nbm.3546","volume":"30","author":"JH Duyn","year":"2017","unstructured":"Duyn, J. H. & Schenck, J. Contributions to magnetic susceptibility of brain tissue. NMR Biomed. 30(4), e3546 (2017).","journal-title":"NMR Biomed."},{"issue":"2","key":"82469_CR26","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/mrm.25420","volume":"74","author":"C Wisnieff","year":"2015","unstructured":"Wisnieff, C. et al. Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of iron. Magn. Reson. Med. 74(2), 564\u2013570 (2015).","journal-title":"Magn. Reson. Med."},{"key":"82469_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.neuroimage.2015.02.045","volume":"112","author":"J Langley","year":"2015","unstructured":"Langley, J. et al. Multicontrast approach for comprehensive imaging of substantia nigra. NeuroImage. 112, 7\u201313 (2015).","journal-title":"NeuroImage."},{"issue":"5","key":"82469_CR28","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1002\/mrm.26584","volume":"78","author":"P Trujillo","year":"2017","unstructured":"Trujillo, P. et al. Contrast mechanisms associated with neuromelanin-MRI. Magn. Reson. Med. 78(5), 1790\u20131800 (2017).","journal-title":"Magn. Reson. Med."},{"issue":"9","key":"82469_CR29","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1002\/mds.27381","volume":"33","author":"MM Lewis","year":"2018","unstructured":"Lewis, M. M. et al. Susceptibility MRI captures nigral pathology in patients with parkinsonian syndromes. Mov. Disord. 33(9), 1432\u20131439 (2018).","journal-title":"Mov. Disord."},{"issue":"1","key":"82469_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/jon.12576","volume":"29","author":"T Kau","year":"2019","unstructured":"Kau, T. et al. Microvessels may confound the \u201cswallow tail sign\u201d in normal aged midbrains: A postmortem 7 T SW-MRI Study. J. Neuroimaging 29(1), 65\u201369 (2019).","journal-title":"J. Neuroimaging"},{"issue":"8","key":"82469_CR31","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","volume":"122","author":"P Damier","year":"1999","unstructured":"Damier, P., Hirsch, E. C., Agid, Y. & Graybiel, A. M. The substantia nigra of the human brain: II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease. Brain 122(8), 1437\u20131448 (1999).","journal-title":"Brain"},{"issue":"5","key":"82469_CR32","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/mds.10459","volume":"18","author":"I Litvan","year":"2003","unstructured":"Litvan, I. et al. SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov. Disord. 18(5), 467\u2013486 (2003).","journal-title":"Mov. Disord."},{"issue":"2","key":"82469_CR33","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/mrm.26140","volume":"77","author":"MR Raman","year":"2017","unstructured":"Raman, M. R., Shu, Y., Lesnick, T. G., Jack, C. R. & Kantarci, K. Regional T1 relaxation time constants in ex vivo human brain: Longitudinal effects of formalin exposure. Magn. Reson. Med. 77(2), 774\u2013778 (2017).","journal-title":"Magn. Reson. Med."},{"issue":"4","key":"82469_CR34","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/mrm.21909","volume":"61","author":"RJ Dawe","year":"2009","unstructured":"Dawe, R. J., Bennett, D. A., Schneider, J. A., Vasireddi, S. K. & Arfanakis, K. Postmortem MRI of human brain hemispheres: T2 relaxation times during formaldehyde fixation. Magn. Reson. Med. 61(4), 810\u2013818 (2009).","journal-title":"Magn. Reson. Med."},{"issue":"4","key":"82469_CR35","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/nbm.3477","volume":"29","author":"C Birkl","year":"2016","unstructured":"Birkl, C. et al. Effects of formalin fixation and temperature on MR relaxation times in the human brain. NMR Biomed. 29(4), 458\u2013465 (2016).","journal-title":"NMR Biomed."},{"issue":"3","key":"82469_CR36","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/j.neuroimage.2012.05.049","volume":"62","author":"C Langkammer","year":"2012","unstructured":"Langkammer, C. et al. Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. Neuroimage. 62(3), 1593\u20131599 (2012).","journal-title":"Neuroimage."},{"issue":"3","key":"82469_CR37","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/nbm.3064","volume":"27","author":"D Zhou","year":"2014","unstructured":"Zhou, D., Liu, T., Spincemaille, P. & Wang, Y. Background field removal by solving the Laplacian boundary value problem. NMR Biomed. 27(3), 312\u2013319 (2014).","journal-title":"NMR Biomed."},{"issue":"1","key":"82469_CR38","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/mrm.21828","volume":"61","author":"T Liu","year":"2009","unstructured":"Liu, T., Spincemaille, P., De Rochefort, L., Kressler, B. & Wang, Y. Calculation of susceptibility through multiple orientation sampling (COSMOS): A method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI. Magn. Reson. Med. 61(1), 196\u2013204 (2009).","journal-title":"Magn. Reson. Med."},{"issue":"7","key":"82469_CR39","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1039\/c0ja00267d","volume":"26","author":"C Austin","year":"2011","unstructured":"Austin, C. et al. Factors affecting internal standard selection for quantitative elemental bio-imaging of soft tissues by LA-ICP-MS. J. Anal. At. Spectrom. 26(7), 1494\u20131501 (2011).","journal-title":"J. Anal. At. Spectrom."},{"issue":"3","key":"82469_CR40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes, A. J., Daniel, S. E., Kilford, L. & Lees, A. J. Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: A clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55(3), 181\u2013184 (1992).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"82469_CR41","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger, G. U. et al. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov. Disord. 32(6), 853\u2013864 (2017).","journal-title":"Mov. Disord."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82469-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82469-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82469-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T21:57:16Z","timestamp":1670018236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82469-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,3]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["82469"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-82469-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,3]]},"assertion":[{"value":"7 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2950"}}